Mirae Asset Global Investments
TEVA icon

Mirae Asset Global Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Mirae Asset Global Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Buy
+8,947
New +$298K ﹤0.01% 1059
2026
Q1 		– Sell
-8,495
Closed -$265K – 1725
2025
Q4 		$265K Buy
8,495
+788
+10% +$19.4K ﹤0.01% 1105
2025
Q3 		$156K Buy
7,707
+2,233
+41% +$39.2K ﹤0.01% 1153
2025
Q2 		$91.7K Buy
5,474
+715
+15% +$11.5K ﹤0.01% 1154
2025
Q1 		$71.8K Buy
4,759
+207
+5% +$3.7K ﹤0.01% 1172
2024
Q4 		$102K Hold
4,552
– – ﹤0.01% 1141
2024
Q3 		$79.5K Buy
4,552
+146
+3% +$2.56K ﹤0.01% 1224
2024
Q2 		$71.6K Buy
+4,406
New +$67.9K ﹤0.01% 1185
2017
Q1 		– Sell
-85,933
Closed -$3.12M – 668
2016
Q4 		$3.12M Buy
85,933
+2,168
+3% +$86.6K 0.07% 194
2016
Q3 		$3.85M Sell
83,765
-19,658
-19% -$1.03M 0.08% 165
2016
Q2 		$5.19M Buy
103,423
+42,617
+70% +$2.27M 0.13% 121
2016
Q1 		$3.25M Sell
60,806
-907
-1% -$53.2K 0.09% 169
2015
Q4 		$4.05M Buy
61,713
+6,809
+12% +$421K 0.13% 144
2015
Q3 		$3.1M Buy
54,904
+9,804
+22% +$636K 0.13% 155
2015
Q2 		$2.67M Sell
45,100
-27,420
-38% -$1.69M 0.09% 177
2015
Q1 		$4.52M Buy
72,520
+21,218
+41% +$1.23M 0.15% 112
2014
Q4 		$2.95M Buy
51,302
+23,423
+84% +$1.3M 0.11% 128
2014
Q3 		$1.5M Buy
27,879
+5,991
+27% +$317K 0.05% 207
2014
Q2 		$1.15M Buy
21,888
+2,438
+13% +$125K 0.03% 236
2014
Q1 		$1.03M Sell
19,450
-7,200
-27% -$333K 0.03% 247
2013
Q4 		$1.07M Sell
26,650
-1,840
-6% -$72.5K 0.04% 270
2013
Q3 		$1.08M Sell
28,490
-1,360
-5% -$53.1K 0.05% 241
2013
Q2 		$1.17M Buy
+29,850
New +$1.16M 0.06% 211

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Mirae Asset Global Investments's TEVA Position: Q2 2026 in Review

Mirae Asset Global Investments opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 8,947 shares worth $303K. The stake represents ﹤0.01% of the portfolio and ranks #1059 among its holdings. This is a return to the name: Mirae Asset Global Investments previously reported a position in TEVA as recently as Q4 2025.

Mirae Asset Global Investments first reported a position in TEVA in Q2 2013 and has held it in 23 quarters since. The position peaked at $5.19M in Q2 2016. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Mirae Asset Global Investments held 8,947 shares of Teva Pharmaceuticals worth $303K as of Q2 2026.
  • Teva Pharmaceuticals was a new Mirae Asset Global Investments position in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1059 holding.
  • Mirae Asset Global Investments first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 23 quarters since.
  • Mirae Asset Global Investments's Teva Pharmaceuticals position peaked at $5.19M in Q2 2016.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.